Bionor Pharma is a leading vaccine company, searching for breakthrough treatments for HIV and other deadly viruses.

Modified Peptide based vaccinesen/Vaccines_+_technology/Platform_technology/The key to kill virusen/Vaccines_+_technology/Platform_technology/Vacc-4x kills virus producing cells.en/Vaccines_+_technology/HIV_vaccine_Vacc-4x/

Latest news

Hide mandatory notifications of trade

Change of Date for Q4 2014 Report

Financial .2015

(Oslo 26 January 2015) Bionor Pharma ASA has changed the date for announcement for its fourth quarter 2014 results to 25 February 2015.

Bionor Pharma Announces Interim Administration

Financial .2015

(Oslo, 25 January 2015). Reference is made to the announcement on 9 January regarding the employment of Dr. David H. Solomon as new CEO of Bionor Pharma ASA.

David Horn Solomon assumes the role as President and Chief Executive Officer of Bionor Pharma ASA

Financial .2015

(Oslo, 9 January, 2015) Bionor Pharma ASA announces the appointment of Dr David Horn Solomon as new President and Chief Executive Officer.

Change of Date for Q4 2014 Report

Financial .2015

(Oslo 26 January 2015) Bionor Pharma ASA has changed the date for announcement for its fourth quarter 2014 results to 25 February 2015.

Bionor Pharma Announces Interim Administration

Financial .2015

(Oslo, 25 January 2015). Reference is made to the announcement on 9 January regarding the employment of Dr. David H. Solomon as new CEO of Bionor Pharma ASA.

Bionor Pharma ASA – Issue of Share Options

Financial .2015

(Oslo, 12 January 2015) Reference is made to the announcement of the appointment of David Horn Solomon as the new CEO of Bionor Pharma ASA 9 January 2015.

Go to news section

Featured content